AFFIRMATIVE ACTION ORDER
OF THE CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On March 1, 2017, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing 4-MePPP and a-PBP into schedule I of the federal Controlled Substances Act. The scheduling action is effective March 1, 2017.
2. The Controlled Substances Board did not receive an objection to similarly treating 4-MePPP and a-PBP as schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating 4-MePPP and a-PBP as controlled substances. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating 4-MePPP and a-PBP as schedule I controlled substances. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats 4-MePPP and a-PBP under chapter 961, Stats. by creating the following: CSB 2.52 Addition of 4-MePPP and a-PBP to schedule I. Section 961.14(7)(L)32. and 33., Stats., is created to read: 961.14(7)(L)32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP.
33. Alpha-pyrrolidinobutiophenone, commonly known as a-PBP.
This order shall take effect on April 10, 2017 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated April 4, 2017 Doug Englebert, Chair
Controlled Substances Board